The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The Rotterdam criteria for polycystic ovary syndrome (PCOS) are used by a wide range of medical professionals and researchers. However, the development of these criteria was based on expert meetings and not on evidence-based treatment guidance. Over the last decade, the Rotterdam criteria have been useful in guiding research, and a number of clinical studies on PCOS have been published consequently. We plead to revisit the Rotterdam criteria based on the available evidence in prognostic studies and randomized controlled trials. In this opinion paper, we provide arguments of the strengths and limitations of the Rotterdam criteria in guiding treatment selections and predicting prognoses in women with infertility. While the Rotterdam criteria have shown their advantages in predicting reproductive prognosis, the next step is to evaluate whether they can guide treatment choices in infertility as well as other health aspects of the syndrome. Based on available data in clinical studies, we should be able to determine whether the Rotterdam criteria are evidence-based criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Imani, B., Eijkemans, M. J. C., te Velde, E. R., Habbema, J. D. F., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02929-6 · Cited by 262
Research works printed but not linked: 27
- Adams, 1985, Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone, Lancet, 2, 1375, 10.1016/S0140-6736(85)92552-8 · DOI · Paper page
- 10.1093/humrep/der396 · DOI · Paper page
- 10.1210/jc.2005-2153 · DOI · Paper page
- 10.1093/humupd/dmu020 · DOI · Paper page
- 10.1093/humrep/der297 · DOI · Paper page
- 10.1093/humrep/des213 · DOI · Paper page
- 10.1093/humupd/dms019 · DOI · Paper page
- 10.1093/humrep/dew027 · DOI · Paper page
- 10.1210/jc.2005-2501 · DOI · Paper page
- 10.1210/jc.2013-1393 · DOI · Paper page
- 10.1210/jc.85.2.676 · DOI · Paper page
- 10.1210/jc.83.7.2361 · DOI · Paper page
- Insler, 1968, Functional classification of patients selected for gonadotropic therapy, Obstet Gynecol, 32, 620
- 10.7326/0003-4819-154-4-201102150-00006 · DOI
- 10.1093/humrep/dev182 · DOI
- 10.1016/S1472-6483(10)61747-6 · DOI
- 10.1136/jnnp.2011.241802 · DOI
- 10.1210/jc.2009-0545 · DOI · Paper page
- 10.1172/JCI108400 · DOI · Paper page
- Swanson, 1981, Medical implications of ultrasonically detected polycystic ovaries, J Clin Ultrasound, 9, 219, 10.1002/jcu.1870090504 · DOI · Paper page
- 10.1093/HUMREP/10.6.1549 · DOI · Paper page
- 10.1093/humrep/dem426 · DOI · Paper page
- 10.1093/humrep/deh891 · DOI
- Vause, 2010, Ovulation induction in polycystic ovary syndrome, J Obstet Gynaecolo Can, 32, 495, 10.1016/S1701-2163(16)34504-2 · DOI
- 1973, Agents stimulating gonadal function in the human. Report of a WHO scientific group, World Health Organ Tech Rep Ser, 514, 1
- Yen, 1980, The polycystic ovary syndrome, Clin Endocrinol (Oxf), 12, 177, 10.1111/j.1365-2265.1980.tb02132.x · DOI · Paper page
- 10.1210/jcem-30-4-435 · DOI · Paper page
Cited by
Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322
Recent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142
Copp, T., Muscat, D. M., Hersch, J., McCaffery, K. J., Doust, J., Dokras, A., Mol, B. W., & Jansen, J. (2022) · Patient Education and Counseling · doi:10.1016/j.pec.2021.05.038 · Cited by 59
Self-citationKrug, I., Giles, S., & Paganini, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s168944 · Cited by 50
“33 Additionally, literature has shown that overall the diagnosis of PCOS is dif fi cult, as the exhibiting signs and symptoms are diverse, depending on the populations assessed, the degree of obesity, and life phase of the women experiencing this disorder.”
BackgroundMethodZirak Sharkesh, E., Keshavarz, S. A., Nazari, L., & Abbasi, B. (2022) · Clinical Endocrinology · doi:10.1111/cen.14672 · Cited by 26
Ajorlouie, Z., Moshkian, P., Baghdadi, G., Amiri, R., Biglari, F., & Rahimlou, M. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01067-5 · Cited by 17
“PCOS diagnosis was confirmed by an expert gynecolo-gist based on the fulfillment of at least two out of three Rotterdam criteria: clinical or biochemical hyperan-drogenism, menstrual irregularities, and polycystic ovarian morphology, after excluding other potential causes of hyperandrogenism [22].”
Unraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
Metabolomic biomarkers of polycystic ovary syndrome related-obesity: a review of the literature
Vonica, C. L., Farcas, A. D., Roman, G., Muresan, A. A., Fodor, A., Cernea, S., & Georgescu, C. E. (2020) · Revista Romana de Medicina de Laborator · doi:10.2478/rrlm-2020-0017 · Cited by 5
Metadata
- Authors
- Wang, R., & Mol, B. W. J.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-09
- Volume
- 32
- Issue
- 2
- Pages
- 261-264
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2552198809
- Cited by
- 138
- References
- 7
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.